about
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio...
Read More
12.87
0.16
(1.26%)
7,362
XNAS Volume
XNAS 14 Jul, 2025 10:25 AM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Korro Bio Inc. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..